Trial Profile
Immunogenicity and Safety of the Purified Vero Rabies Vaccine - Serum Free (VRVg) in Comparison With the Human Diploid Cell Vaccine, Imovax Rabies in a Pre-exposure Prophylaxis Regimen in Healthy Children and Adolescents Aged 2 to 17 Years
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Aug 2022
Price :
$35
*
At a glance
- Drugs Rabies-vaccine-inactivated-Sanofi (Primary)
- Indications Rabies
- Focus Therapeutic Use
- Sponsors Sanofi
- 26 Jul 2022 Results assessing the non-inferiority of the immune response and assess the safety profile of PVRV-NG versus a licensed human diploid cell culture rabies vaccine (HDCV) in a pre-exposure regimen in healthy children and adolescents in the Philippines, published in the Vaccine.
- 02 Sep 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 05 Mar 2015 According to the ClinicalTrials.gov record, planned end date changed from 1 Dec 2014 to 1 Jun 2015.